Literature DB >> 33333591

Impact of margin status on survival after radical nephrectomy for renal cell carcinoma.

Lindsay K Morris1, Alaa Altahan2, Jatin Gandhi3, John Mays1, Upama Giri4, Martin Fleming5, Mike G Martin6.   

Abstract

BACKGROUND: Data about the impact of surgical margin positivity on patient outcomes following radical nephrectomy (RN) for renal cell carcinoma (RCC) is limited. We evaluate the effect of positive surgical margins (PSMs) on relapse-free survival (RFS) and overall survival (OS.)
METHODS: Clinicopathologic data of patients who underwent RN for RCC was analyzed based on margin status. χ2 and Student t test were used to compare groups. Cox regression analysis was used for the analysis. Kaplan-Meier method was used for survival curves.
RESULTS: A total of 485 patients who underwent RN for RCC were analyzed. Most patients with T1/T2 stage had NSM. Most patients with T4 had PSM. T3 patients were split between the two groups. Analysis of the T3 group showed shorter RFS in the PSM group at 3 years (hazard ratio [HR]: 4.3, p = .01), and 5 years (HR: 4.3, p = .01.) OS analysis showed worse OS in PSM but not statistically significant. There was a significant association between PSM and laterality (p = .023) and histologic type (p = .025.)
CONCLUSIONS: PSM was associated with shorter RFS after RN in T3 RCC patients. There was a trend towards worse OS in the PSM group, but it did not reach statistical significance. Laterality and histologic type were associated with surgical margin status.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  multivariate analysis; overall survival; radical nephrectomy; recurrence-free survival; renal cell carcinoma; surgical margins

Year:  2020        PMID: 33333591     DOI: 10.1002/jso.26321

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Partial and Radical Nephrectomy Provides Equivalent Oncologic Outcomes in pT3a Renal Cell Carcinoma: A Population-Based Study.

Authors:  Jihua Tian; Xing Zeng; Jie Wan; Jiahua Gan; Chunjin Ke; Wei Guan; Zhiquan Hu; Chunguang Yang
Journal:  Front Oncol       Date:  2022-01-26       Impact factor: 6.244

2.  Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer.

Authors:  Shengtao Dong; Hua Yang; Zhi-Ri Tang; Yuqi Ke; Haosheng Wang; Wenle Li; Kang Tian
Journal:  Front Oncol       Date:  2021-11-25       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.